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A highly specific Diels-Alder protein catalyst was made by manipulating the antibody
repertoireoftheimmunesystem.Thecatalyticantibody13G5catalyzesadisfavoredexo
Diels-Alder transformation in a reaction for which there is no natural enzyme counterpart
and that yields a single regioisomer in high enantiomeric excess. The crystal structure
of the antibody Fab in complex with a ferrocenyl inhibitor containing the essential
haptenic core that elicited 13G5 was determined at 1.95 angstrom resolution. Three key
antibody residues appear to be responsible for the observed catalysis and product
control. Tyrosine-L36 acts as a Lewis acid activating the dienophile for nucleophilic
attack, and asparagine-L91 and aspartic acid–H50 form hydrogen bonds to the car-
boxylate side chain that substitutes for the carbamate diene substrate. This hydrogen-
bondingschemeleadstorateaccelerationandalsopronouncedstereoselectivity.Dock-
ing experiments with the four possible ortho transition states of the reaction explain the
specific exo effect and suggest that the (3R,4R)-exo stereoisomer is the preferred
product.
The Diels-Alder reaction is the quintessen-
tial pericyclic transformation in organic
chemistry (1). The reaction of a diene with a
dienophile provides enormous opportunities
to generate cyclic structures. This reaction is
facilitated by the presence of electron-donat-
ing groups on the diene and electron-with-
drawing functionalities on the dienophile
(2). Detailed studies of Diels-Alder reac-
tion rates have shown some dependency
on the solvent (3); for example, in aque-
ous solution, the Diels-Alder reaction is
often accelerated as a consequence of hy-
drogen bonding of water to the dienophile
in the transition state. Because of its syn-
thetic importance, substantial interest has
arisen in the theoretical aspects of this
reaction. Various reaction schemes have
been proposed that range from biradical to
synchronous bond formation (2).
The immune system has been shown to
generate various de novo antibody catalysts
(4). The application of transition state the-
ory in hapten design (5), based on the
reaction mechanism, led to the initial pro-
duction of esterolytic antibodies (6). Fur-
ther advances in transition state analog de-
sign, combined with “bait and switch” (4)
and the strategy of reactive immunization
(7), have resulted in an impressive array of
catalytic antibodies that can effect a wide
range of chemical transformations (4).
A desirable goal has been the genera-
tion of antibody catalysts for which enzy-
matic counterparts are not available (8).
The existence of a natural Diels-Alderase
enzyme has been proposed (9), but its
function and catalytic mechanism have
not yet been characterized. Structural
studies of antibody-hapten complexes can
supply information on how such reactions
are catalyzed and allow comparison with
natural enzymes, when they exist, as well
as suggest how mutations might improve
their catalytic rates. These principles were
aptly demonstrated with the catalytic an-
tibody structure of 1F7 (10), which con-
verts chorismate to prephenate in a peri-
cyclic process related to the Diels-Alder
reaction.
The exo Diels-Alder reaction forms a
trans cyclohexene adduct 3 from 4-car-
boxybenzyl trans-1,3-butadiene-1-carba-
mate (1) with N,N-dimethylacrylamide
(2) (Fig. 1). This Diels-Alder reaction is
disfavored relative to the formation of the
endo-cis adduct 4. Two approaches have
been used to generate antibodies capable
of catalyzing the Diels-Alder reaction.
The first used conventional, rigid, bicyclic
transition state analogs to elicit antibody
catalysts (11), in which the distribution of
products could be controlled for the reac-
tion between the diene and dienophile
(Fig. 1). With this strategy, specific endo
and exo Diels-Alder antibodies were se-
lected with bicyclic haptens 5 and 6 (12).
A more radical approach in hapten design
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Fig. 1. A disfavored
exo Diels-Alder reaction
catalyzed by antibody
13G5. The 4-carboxy-
benzyl trans-1,3-buta-
diene-1-carbamate 1
reacts with N,N-di-
methylacrylamide 2 to
form the cyclohexene
product 3 (Me, methyl).
The less energetically
favorable exo product 3
is formed rather than
the endo product 4. The
inhibitor 1-carboxy-19-
[(dimethylamino)carbonyl]
ferrocene 9 is the core
structure of the original
hapten and was used for
both antibody-hapten af-
finity measurements (13)
andinourcrystallographic
studies because this
compound is more chem-
ically stable. The 1-[(4-
carboxy-1-oxobutyl)ami-
no]-19-[(dimethylamino)-
carbonyl]ferrocene com-
plex 7 was linked to key-
hole limpet hemocyanin
and used as a hapten to
elicit 13G5. The constrained bicyclo[2.2.2]octene hapten 5 was originally chosen because it is a close
mimic of the transition state in the Diels-Alder reaction (11). The product distribution, Michaelis constant
(Km), catalytic rate constant (kcat), and rate enhancement [expressed as effective molarity (E.M.)], for the
catalyticantibodiesgeneratedwith5and6(12)andwithferrocenylcompounds7and8(13)arecompared
in the table. Uncat., uncatalyzed.
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ative 7 as a transition state analog for
antibody generation. This hapten is highly
flexible, with the cyclopentadienyl rings
able to rotate freely in solution. We chose
this hapten to test whether the immune
system can select a conformer that mimics
one of the Diels-Alder transition states
and, hence, produce a specific Diels-Al-
derase (13), and to challenge the concept
that the best haptens for reactions that
proceed through highly ordered transition
states must be conformationally restricted.
Antibody 13G5 was raised to 7, which had
been linked through its carboxylic acid
group as an amide to keyhole limpet he-
mocyanin. The antibody catalyzes the dis-
favored exo Diels-Alder reaction of sub-
strates 1 and 2 (Fig. 1) (13) and catalyzes
the formation of the ortho product with
high regio-, diastereo-, and enantioselec-
tivity, forming only one out of eight pos-
sible products. In comparison, the uncata-
lyzed reaction of these substrates is only
regioselective, with a ratio of ortho-endo
to ortho-exo products of 85:15. The ortho
transition state is predicted to be 2 to 4
kcal/mol lower in energy than the meta
transition state, with the endo transition
states being about 1.9 kcal/mol lower in
energy than the exo transition states (12).
In the uncatalyzed reaction, no enantio-
meric preference was observed (Fig. 1).
We report here crystallographic studies
on a complex of this catalytic antibody with
the more stable inhibitor 9, which was also
used for antibody-hapten affinity measure-
ments (13). We also determined the crystal
structure of the unbound inhibitor and per-
formed quantum mechanical calculations to
probe the catalytic mechanism of this Diels-
Alder reaction. Docking of the four possible
ortho transition states revealed the basis for
the stereo- and enantioselectivity.
The crystal structure of the Fab-ferro-
cene complex was determined to 1.95 Å
resolution with good stereochemistry (Ta-
ble 1). The overall structure is very similar
to other known Fab structures (Fig. 2). The
elbow angle (14) of 146.5° is in the middle
of the observed range (127° to 227°) for
antibodies (15). The inhibitor is completely
buried (99%) in the antibody combining
site with 231 Å2 of its 233 Å2 surface area
(14) being inaccessible to solvent, as has
been found for the binding of other small
haptens such as a chorismate mutase tran-
sition state analog (.90%) and fluorescein
(94%) (10, 16). In the antibody, 305 Å2 of
solvent-accessible surface is buried upon
complexation (44% of VL and 56% of VH)
(Fig. 3).
Three hydrogen bonds are made from
the cyclopentadienyl metal complex (in-
hibitor) to the antibody (Fig. 4). The TyrL36
residue (position prefixes L and H designate
light and heavy chains, respectively) forms
a short hydrogen bond of 2.5 Å with the
carbonyl oxygen of the (dimethylamino)-
carbonyl group; this ferrocenyl amide mim-
ics the N,N-dimethylacrylamide found
within dienophile 2. Two hydrogen bonds
are formed from the ferrocenyl carboxylic
acid (this functionality represents the car-
bamate found on diene 1) to the side chain
amino group of AsnL91 (2.9 Å) and to the
carboxyl of AspH50. The hydrogen bond to
AspH50 (2.5 Å) requires either the aspartic
acid or the ferrocene carboxyl group to be
protonated. At the pH of crystallization
(;6.5), it is more likely that the carboxyl
group of the inhibitor is protonated. Each of
the Fab residues that form these three hy-
drogen bonds to the inhibitor have their
side chains fixed in position by an extensive
hydrogen-bonding network (Fig. 4). The
AsnL91 residue is oriented by a hydrogen
bond to the protonated nitrogen of the
imidazole of HisL32. The other nitrogen of
HisL32 acts as a proton acceptor and forms a
hydrogen bond with NHd2o fA s n L27D [an-
tibody nomenclature described in (17)].
The third hydrogen bond of the network is
formed between the OHg of SerL27E and
Od1o fA s n L27D. Residue AspH50 is able to
Fig. 2. Stereoview of the catalytic antibody Fab 13G5 in complex with the ferrocene compound 9,
showingtheinhibitordeeplyboundintheantibodycombiningsite.Thesideviewshowsthevariablelight
chain (VL) on the left in magenta and the variable heavy chain (VH) on the right in cyan, with the hapten
in ball-and-stick representation. Figures 2, 3, and 6 were produced with AVS (31).
Fig. 3. Stereoview of the antibody combining site, slicing through the molecular surface of the 13G5
variable domain (1.5 Å sphere radius) and 9. The cyclopentadienyl ferrocene complex 9 is deeply buried
in the antibody combining site and shielded from excess solvent. The Ca trace of the light chain is
superimposed on the left in magenta and the heavy chain on the right in cyan. This close-up view shows
the ferrocene inhibitor bound in a deep pocket with a narrow entrance through which the linker of the
actual hapten 7 used for immunization could extend.
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nitrogen atom of the indole ring of frame-
work residue TrpH47. Residue TyrL36, which
is directed toward the dienophile portion of
the inhibitor, is oriented by an additional
hydrogen bond from its side chain hydroxyl
to the main-chain amide of Gly100B.Aw a -
ter molecule O87 interacts directly with the
inhibitor and forms a hydrogen bond (3.0
Å) with the carboxyl side chain of the
cyclopentadienyl ring. Additional bridging
water hydrogen bonds are formed with
AsnL91 and GlyH100A (3.2 Å and 2.9 Å,
respectively).
A total of 45 van der Waals interactions
(17 with VL, 28 with VH) are made between
the antibody and the ferrocene inhibitor.
These interactions mainly reside within the
residues of the complementarity-determin-
ing region (CDR) loops [L1 (3), L3 (10),
H1 (4), H2 (6), and H3 (13)] as expected
(Fig. 2). No interactions are made with
CDR L2 as is usually observed when small
haptens are antigens (15).
The unbound cyclopentadienyl ferro-
cene 9 crystal structure (Fig. 5) contains
two molecules of 1-carboxy-19-[(dimethyl-
amino)carbonyl]ferrocene 9 in the asym-
metric unit (18). Bond lengths and angles
are comparable to a similar metalloligand,
ferrocene-1,19-dicarboxylic acid, for which
highly accurate low-temperature x-ray data
and neutron studies are available (19). In
each molecule of 9, the 1,19-substituents
from the cyclopentadienyl rings are orient-
ed in an anti conformation that minimizes
steric intramolecular interactions. In one of
these molecules, both of the disubstituents
are nearly coplanar with the cyclopenta-
diene ring [torsion angles of 9.6° (N1-C11-
C1-C2) and 8.2° (C5-C1-C11-O1)]. In the
second molecule, the (dimethylamino)car-
bonyl group is rotated out of plane [torsion
angles of 34° (C59-C19-C119-O19) and
45.4° (C29-C19-C119-N19)], and the car-
bonyl oxygen forms a hydrogen bond to the
carboxyl group of a symmetry-related mol-
ecule (Fig. 5). A second hydrogen bond is
formed between the carbonyl oxygen of
molecule 1 and the carboxyl group of mol-
ecule 2 (Fig. 5). In the ferrocene-1,19-
dicarboxylic acid structure, the two acid
groups are coplanar with the cyclopenta-
dienyl rings and form hydrogen bonds with
neighboring molecules. The energy barrier
for rotation of the rings with respect to
each other is very low in solution (;2t o
5 kcal/mol) (13). However, in the crystal-
line state, the formation of hydrogen
bonds seems to determine the relative ar-
rangement of the side groups.
In the antibody-antigen complex, the
ferrocene ring rotation is restricted because
of steric constraints and specific interac-
tions with the antibody. The position and
orientation of the substituents on 9 are
determined by maximizing the number of
hydrogen bonds that the ferrocene inhibitor
can form with the protein (Fig. 4). Thus,
the antibody is able to trap one conformer
of the cyclopentadienyl compound. The
electron density for 9 at this resolution is
AB
TyrL36
TyrL36
TrpH47
AspH50
AsnL91
AsnL27D
SerL27E
GlyH100B
GlyH100A
HisL32
AsnL91
AspH50
2.5
O87
2.9
2.5
2.8 2.9
3.2
3.3
2.9
Inhibitor
3.0
2.5
2.5
2.9
2.9 2.9
O87
Fig. 4. Specific interac-
tions of 9 with side
chains of the Fab 13G5
in the antibody-antigen
complex. Three hydro-
gen bonds are formed
with Fab residues TyrL36,
AspH50, and AsnL91.I n
addition, a water mole-
cule O87 is in close con-
tact to ferrocene 9. The
hydrogen-bonding net-
work in the Fab combin-
ing site that orients the
side chains of TyrL36,
AspH50, and AsnL91 in position to form hydrogen bonds with 9 are shown in
(B). For AsnL91, this network is extended over three residues. Oxygen atoms
are shown in red and nitrogen atoms in blue. Figures 4 and 5 were produced
with XP (31).
12 1 a
Fig. 5. The crystal structure of
1-carboxy-19-[(dimethylamino)car-
bonyl]ferrocene 9. Molecules 1 and
2 are within the asymmetric unit,
and 1a is a symmetry-related mol-
ecule. The molecules are connect-
ed by a hydrogen-bonding scheme
between the carboxylate and the
N,N9-dimethylformamide that re-
sults in an anti conformation of the
1,19-substituents.
Fig. 6. Omit electron density map (Fo 2 Fc), contoured at an interval of 1.1s,o f9 in the Fab com-
plex. The map has been colored according to the gradient of the density (32) in increasing order
(yellow, green, cyan, purple), showing the highest gradient in purple surrounding the iron atom. The
final ferrocenyl inhibitor model is superimposed on the density. The close-up view from the top
into the antibody combining site shows the surrounding light chain in magenta and the heavy chain
in cyan.
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der or multiple conformers for either of the
1,19-substituents (Fig. 6). The eclipsed
stacking appears energetically less favorable
than the antiperiplanar conformation seen
with 9 (Fig. 5), but it is compensated for by
formation of hydrogen bonds to the Fab,
similar to the ferrocene-1,19-dicarboxylic
acid structure (19), as well as by multiple
hydrophobic interactions. The (dimethyl-
amino)carbonyl group is slightly rotated out
of the ring plane with torsion angles of
–27.7° (C5-C1-C11-O1) and –23.6° (C2-
C1-C11-N1), which are less than in the
second molecule of the small molecule
structure. Again, these torsion angles ap-
pear to be restricted by formation of a hy-
drogen bond.
The ferrocene inhibitor 9 acts as a loose
mimic for a very early transition state of the
Diels-Alder reaction, where the (dimethyl-
amino)carbonyl group of the ferrocene rep-
resents the monosubstituted dienophile and
the carboxyl group corresponds to the side
chain of the diene (Fig. 1). Three hydrogen
bonds constrain the orientation of the 1,19-
disubstituted ferrocene 9 in the Fab com-
plex. When the actual transition state for
the substrates of the reaction is reached
(which is closer to the geometry of the
product), the main-chain amide group of
GlyH100B and the water molecule O87 might
also be available for hydrogen bonding to
the dienophile. We suggest that, in the
transition state of the reaction, the carbonyl
oxygen of the amide forms a hydrogen bond
to the OHh group of TyrL36, and the NH of
the diene carbamate forms a hydrogen bond
to AspH50, resulting in increased charge
transfer and catalytic rate enhancement of
the diene-dienophile.
Studies of solvent effects and theoretical
calculations on the Diels-Alder reaction
have shown that the C1-O– polarization of
the carbonyl group of the dienophile is
enhanced in the transition state. This en-
hanced polarization leads, for example, to a
stronger hydrogen bond at the carbonyl ox-
ygen of methyl vinyl ketone in the reaction
with cyclopentadiene and results in a rate
acceleration in water (3). The energy gain
is about 1.5 to 2.0 kcal per hydrogen bond,
with an average number of hydrogen bonds
per dienophile of 2 to 2.5 (3). The lowest
energy transition state has a water hydrogen
bonded to the methyl vinyl ketone carbon-
yl, syn to the double bond (3). These energy
differences are small (0.2 to 0.8 kcal/mol)
(3), but the same preference is observed in
the hydrogen bond formation of the transi-
tion state analog 9 with TyrL36 in our struc-
ture and in the modeled exo transition
states, where the hydrogen bond is on the
same side as the double bond of the dieno-
phile (Figs. 4 and 7).
The carboxylate substituent on ferro-
cene 9 is fixed by the interaction with
AsnL91, AspH50, and water O87 (Fig. 4). In
addition to the hydrogen bonds, 45 van der
Waals interactions are made between in-
hibitor and antibody 13G5. From the 17
formed with VL, only two involve carbon
atoms (C1 and C5) of the cyclopentadienyl
rings, whereas the remaining interactions
are almost exclusively with the (dimethyl-
amino)carbonyl group on 9. These interac-
tions severely restrict rotation about the
ring-iron-ring axis, because the (dimethyl-
amino)carbonyl appendage would collide
with neighboring protein atoms. However,
the carboxylic acid on 9 appears to be steri-
Table 1. Crystallization, data collection, structure solution, and refinement for the antibody-hapten
complex. Antibody 13G5 (immunoglobulin G1, k) was digested to a Fab with mercuripapain, which had
been activated by incubation with cysteine and EDTA as described (26). Crystals were grown in 14%
MPEG2000,0.1McacodylateatpH6.5insittingdropsbythevapordiffusionmethod.Crystallineplates
of moderate size (0.33 by 0.17 by 0.03 mm3) were obtained after a 2-day equilibration period and
addition of 100 mM NaCl to the well solution. The light-sensitive ferrocenyl complex 9 was soaked into
preformed crystals for 12 hours in the dark. A 9–Fab 13G5 data set was collected at beamline 7-1 at the
Stanford Synchrotron Radiation Laboratory (SSRL) on a Mar image plate detector at –176°C with 30%
glycerol as cryoprotectant. Data were processed with DENZO (27) and SCALEPACK (27). The Fab
structure was determined by molecular replacement [AMORE (27)], with the native Fab (28)a st h e
search model. A rigid-body refinement of the individual domains was performed in X-PLOR (27) from 10
to 4 Å, with subsequent multiple rounds of positional refinement in increasing shells of data from 10 to
3 Å up to 10 to 1.95 Å with R 5 35.5% for this resolution range. Refinement was continued with the
program SHELXL-96 (27). Multiple rounds of model building with the program O (27) followed by
refinement were performed with standard restraints on bond distances and angles and a SIMU (assum-
ing similar B values for spatially adjacent atoms) restraint of 0.1 for B values. For model building,
sA-weighted (27)3 Fo –2 Fc and Fo – Fc maps were calculated as implemented in SHELXPRO (27)a s
well as 2Fo – Fc and Fo – Fc shake omit maps, omitting ;10% of the residues, with X-PLOR (27). In the
final stages, hydrogen atoms were placed in calculated positions for Fab residues and refined without
use of additional parameters. For the transition state analog, the iron atom was positioned into density,
and after one additional round of refinement, density was clearly visible for the complete inhibitor. The
inhibitor was built into difference electron density and refined with geometric restraints on bond lengths
and angles. Distances were chosen from the small molecule structure and similar structures reported in
the literature (19). The cyclopentadienyl rings and amide group were restrained to be planar. Rotation
around the ring-center iron axis and out-of-plane rotation of the dimethylacrylamide group was not
restricted. An overall anisotropic scaling and diffuse solvent correction was applied. The overall electron
density was very clear, allowing precise positioning of side chains, except for an external loop region in
the constant heavy chain (H129 to H135), which is frequently disordered in other antibody structures
(29). Analysis of the stereochemical quality of the model shows 92.9% of all residues are in the most
favored regions and only one residue (MetL51) is in a disallowed region, but it is in a g turn, as commonly
observed in other antibody structures (30).
Crystallographic parameter Value
Refinement statistics
Space group C2
Unit cell dimensions a 5 182.9 Å, b 5 40.5 Å, c 5 67.7 Å, b5109.0°
Matthews constant (Å3/dalton) 2.37
Resolution range (Å) 40.0–1.95
Observations 188,444
Unique reflections 32,813
Completeness (%) 95 (84)*
I/sI† 30.5 (10.1)*
Rmerge (%)‡ 3.3 (12.3)*
Refined residues (N) 435
Refined water molecules (N) 309
Refinement range (Å) 10.0–1.95
Rcryst (%)§ 17.8 (28,940 Fo . 4sFo)
18.4 (30,944 Fo $ 0)
Rfree (%)\ 25.3 (1520 Fo . 4sFo)
26.5 (1628 Fo $ 0)
Deviations from ideal geometry (rms)
Bond lengths (Å) 0.006
Bond angles (°) 1.72
Dihedral angles (°) 29.9
Improper angles (°) 1.71
B values
Average B value (Å2) 22.0
Waters (Å2) 28.1
Ferrocene inhibitor (Å2) 15.3
*Values for data in outer shell of 2.02 to 19.5 Å. †The signal-to-noise ratio. ‡Rmerge 5S ïFo
2 2 Fo
2ï/
SFo
2. §Rcryst 5 100 3S ïFo – Fcï/SïFoï, where Fo and Fc are the observed and calculated structure factors,
respectively. \Rfree is calculated in the same manner as Rcryst, but from 5% of the data that was not used for
refinement.
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that there is enough space in the binding
site for rotation of the upper ring by about
one ring-carbon position (one-fifth rotation
or ;72°) without interfering with Fab at-
oms. Hence, it appears that hydrogen bond-
ing from the Fab to the inhibitor carboxy-
late fixes the relative orientation of the
upper ring. Further rotation is restricted
because of steric hindrance with the main-
chain atoms of residues GlyH35, AlaH93,
GlyH100B, and the side chain of AspH50.
Also, the staggered conformation, as seen in
the small molecule 9, is not possible be-
cause of the position of AlaH93. The heavy
chain forms most of its van der Waals con-
tacts with the cyclopentadienyl rings; the
cyclopentadienyl ring mimicking the diene
functionality makes 17 contacts and the
corresponding dienophile ring makes 11
contacts. Thus, extensive hydrophobic con-
tacts with the Fab play an important role in
hapten binding and form a suitable envi-
ronment for a bound hydrophobic ligand.
In the actual hapten 7 used to elicit the
antibody, the carboxylate of 9 is replaced by
a( 4 -carboxy-1-oxylbutyl)amino appendage
(Fig. 1). This functionality can be compared
to the N-butadienyl-carbamic acid that was
used as a model compound for the Diels-
Alder reaction described previously (12).
The question arises as to how the antibody
accommodates the actual hapten used for
immunization, and which, if any, of the car-
boxyl group oxygens of 9 correspond to ei-
ther the nitrogen or the carbonyl oxygen of
the carbamate 7. This hapten can be mod-
eled onto the ferrocene derivative by over-
lapping the lower “dienophile” ring and
maintaining the position of the (dimethyl-
amino)carbonyl group. The upper “diene”
ring now becomes more restricted in the
binding site because of the bulkier (4-car-
boxy-1-oxylbutyl)amino functionality but
still can be modeled in both exo and endo
conformations. However, only the exo con-
former can form hydrogen bonds with the
Fab. In this conformation, AspH50 can form
a hydrogen bond (;3 Å) with the amine,
and AsnL91 hydrogen bonds to the carbonyl
oxygen (;2.5 Å). In the structure of 9, the
carboxyl oxygen that hydrogen bonds to
AspH50 corresponds to the amide nitrogen of
7, and the second carboxyl oxygen, in con-
tact with AsnL91, is equivalent with the car-
bonyl oxygen of the carbamate. Thus, equiv-
alent hydrogen bonds can be formed with
the same Fab residues to the carbamate on 7
as with the carboxylate of 9.
Ab initio calculations suggest that two of
these three hydrogen-bonding interactions
described above result in transition state sta-
bilization. The extent of catalysis possible
from these interactions was determined from
quantum mechanical investigations of the
transition states of the Diels-Alder reaction
of N,N-dimethylacrylamide with N-butadi-
enyl carbamic acid, a model for diene 1. The
geometries of the reactants and transition
states were optimized with RHF/3-21G ab
initio calculations (20, 21), and energies
were evaluated with density functional the-
ory at the Becke3LYP/6-31G* level (22, 23).
One exo transition state of the reaction
(Fig. 7), and those obtained when the acryl-
amide is hydrogen-bonded to a water mole-
cule or when the carbamate NH is hydrogen-
bonded to a formate constitute model sys-
tems in which water corresponds to the side
chain OHh of TyrL36 and formate mimics
the carboxyl group of AspH50. The hydrogen
bond between water and the acrylamide sta-
bilizes the complex by 6.3 kcal/mol; this
interaction lowers the lowest unoccupied
molecular orbital and increases the reactivity
of the dienophile. In the transition state, the
strength of the hydrogen bond increases to
7.4 kcal/mol, resulting in a decrease of 1.1
kcal/mol in the activation energy of the re-
action. However, the hydrogen bond be-
tween acrylamide and the side chain OHh of
TyrL36 by itself is unlikely to account for
most of the catalytic effect observed for
13G5 because the uncatalyzed reaction oc-
curs in aqueous solution where hydrogen
bonds between acrylamide and water also
result in transition state stabilization.
The formation of a short, strong hydro-
gen bond between formate and the NH of
the diene carbamate substituent actually re-
sults in a much larger activation energy
decrease of 5.9 kcal/mol (Fig. 7C). Thus, a
hydrogen bond between the NH of the
diene carbamate and the carboxylate of
AspH50 in 13G5 is predicted to be more
important than the hydrogen bond to the
dienophile in inducing rate acceleration.
These hydrogen-bonding interactions
each cause increased asynchronicity and
charge separation in the transition state.
When both are present (Fig. 7D), the ef-
A
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Fig. 7. RHF/3-21G transition structures for the exo
Diels-Alder reaction of N,N-dimethylacrylamide
and N-butadienyl carbamic acid without (A) and
with (B) water hydrogen-bonded to the dienophile
carbonyl oxygen, with formate hydrogen-bonded
to the diene (C), and with hydrogen bonds to both
water and formate (D). Activation energies for (A),
(B), (C), and (D) are 22.2, 21.1, 16.3, and 12.2
kcal/mol,respectively,andarefromBecke3LYP/6-
31G*//HF/3-21G 1 HF/3-21G ZPE calculations
(20–23). All bond lengths are in angstroms, and
oxygen atoms are in red, nitrogen atoms in blue,
and carbon atoms in white. Figures 7 and 8 were
produced with MOLMOL (31).
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Fig. 8. Favored orientations for each of the four isomeric transition states in antibody 13G5 predicted by
AUTODOCK: (A)( 3 R,4R)-exo,( B)( 3 S,4S)-exo,( C)( 3 R,4S)-endo, and (D)( 3 S,4R)-endo. The lowest
energy structures in (A), (C), and (D), and the second lowest in (B) are shown. Only the transition states
of the reaction (Fig. 1) and the interacting side chains that form hydrogen bonds in the crystal structure
of the ferrocenyl inhibitor are shown for clarity. Only in the exo forms are all three hydrogen bonds made
that are observed in the crystal structure of the inhibitor-Fab complex.
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ergy is decreased by 10 kcal/mol relative to
the uncatalyzed reaction. Thus, the pres-
ence of both hydrogen bonds is required for
maximum rate acceleration. If only a subset
of the stereoisomeric Diels-Alder transition
states is capable of binding in orientations
that preserve both of these hydrogen bonds,
then both rate acceleration and stereospec-
ificity are possible.
The Fab–ferrocene inhibitor complex
structure provides a key to understanding
the ability of 13G5 to achieve complete exo
versus endo stereoselectivity and high en-
antioselectivity in a Diels-Alder reaction.
We have explored the mechanism of this
high specificity by investigating how each
of the four possible transition states might
interact with the Fab 13G5 combining site.
The transition states were constructed from
ab initio RHF/3-21G calculations on the
reactions of N-butadienylcarbamate with
N,N-dimethylacrylamide. One of the exo
transition states is shown in Fig. 7. For the
modeling studies, the acidic hydrogen of
each transition state was replaced by a stan-
dard benzyl carboxylate side chain.
The four stereoisomeric transition states
were docked (24) into the binding site of
13G5. The (3R,4R)-exo transition state docks
in a fashion roughly similar to 9, with hydro-
gen bonds between TyrL36 and the dieno-
phile carbonyl group, AspH50 and the NH of
the diene carbamate, and AsnL91 with the
carbonyl group of the carbamate. This dock-
ing mode provides both of the hydrogen
bonds postulated to accelerate the Diels-Al-
der reaction. Although one might have ex-
pected that the transition state that most
closely overlays the ferrocenyl complex 9
would be the most highly stabilized, docking
calculations suggest that the (3R,4R)-exo en-
antiomer should be stabilized most by hydro-
gen interactions with the antibody. The tran-
sition state that is closest to the ferrocenyl
complex 9, (3S,4S)-exo, can also dock in an
orientation that preserves the two catalytic
hydrogen bonds (Fig. 8B). However, the low-
est energy docking mode for (3S,4S)-exo lacks
the activating hydrogen bonds to the diene
amide and dienophile carbonyl. Both endo
transition structures dock readily into the
binding site (Fig. 8, C and D) but lack hy-
drogen bonds to the dienophile carbonyl ox-
ygen or to the diene amide.
We conclude then that the exo transition
states can be bound in orientations that al-
low formation of hydrogen bonds to both the
diene and dienophile moieties. The strength
of these hydrogen bond interactions is in-
creased in the transition state because of
charge transfer from diene to dienophile.
The endo transition states bind in orienta-
tions that do not allow formation of these
strong hydrogen bonds. The (3R,4R)-exo
transition structure appears to be the most
highly stabilized, but definitive evidence can
only be obtained by determination of the
absolute configuration of the product ob-
tained from the 13G5 catalysis (25).
The binding pocket of antibody 13G5
thus provides enough space to accommodate
all four possible ortho transition states of the
Diels-Alder reaction. However, only in the
exo transition state can the same hydrogen
bonds be formed that are seen in the struc-
ture of the ferrocene complex 9. The role of
TyrL36 can be entirely attributed to rate en-
hancement, which is due to its Lewis acid
effect on the dienophile, thus activating it
for nucleophilic attack. Hydrogen bonding
to AspH50 decreases the activation energy
even more because the negatively charged
Asp makes the carbamate of the diene a
much better electron donor and, together
with AsnL91, provides the structural frame-
work for the antibody to orient and position
the substrates for catalysis. A greater catalyt-
ic rate enhancement than the observed kcat
of 1.20 3 1023 min21 could be achieved by
introduction of either a stronger or an addi-
tional electrophile within hydrogen-bonding
distance to the dienophile. The resulting
increased electron-withdrawing effect should
enable a more efficient nucleophilic attack
on the dienophile. Furthermore, mutation of
AsnL91 to Asp and AspH50 to Asn might
change the reaction pathway, shifting the
catalysis toward the endo Diels-Alder reac-
tion. Further kinetic and crystallographic
analyses of these mutants with and without
bound substrates should provide additional
insights into this proposed reaction mecha-
nism for a Diels-Alder reaction and in the
evolution of protein catalysts for disfavored
processes.
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RNA Folding at Millisecond Intervals by
Synchrotron Hydroxyl Radical Footprinting
Bianca Sclavi, Michael Sullivan, Mark R. Chance,*
Michael Brenowitz,* Sarah A. Woodson*
Radiolysis of water with a synchrotron x-ray beam permits the hydroxyl radical–acces-
sible surface of an RNA to be mapped with nucleotide resolution in 10 milliseconds.
ApplicationofthismethodtofoldingoftheTetrahymenaribozymerevealedthatthemost
stable domain of the tertiary structure, P4-P6, formed cooperatively within 3 seconds.
Exterior helices became protected from hydroxyl radicals in 10 seconds, whereas the
catalytic center required minutes to be completely folded. The results show that rapid
collapse to a partially disordered state is followed by a slow search for the active
structure.
The speed of chemical reactions carried
out by ribozymes is often limited by confor-
mational changes in the RNA (1). As a
result, the process by which RNA molecules
fold into their native conformation has re-
ceived much attention. Early investigations
into the folding of tRNA established ap-
proximate time scales for the formation of
RNA secondary (1024 to 1025 s) and ter-
tiary interactions (1022 to 1021 s), with
the reorganization of incorrect secondary
structures occurring more slowly (0.1 to
1s )( 2). Recent work has shown that
folding of large RNAs is more complex
(3), involving multiple pathways (4). In-
dividual domains of an RNA may form at
rates that differ by orders of magnitude,
with some transitions requiring minutes to
reach completion (3–7). Identification of
the paths by which large RNAs fold has
been hampered by the lack of experimen-
tal methods capable of probing RNA con-
formation with nucleotide resolution at
subsecond time scales (8). Here, we de-
scribe direct measurement of the complete
folding pathway of the Tetrahymena ri-
bozyme by hydroxyl radical footprinting
using a synchrotron x-ray beam.
Hydroxyl radical ribose oxidation and
resulting strand cleavage are correlated with
the solvent accessibility of the RNA back-
bone (9, 10) and are insensitive to base
sequence and secondary structure (11).
Generation of hydroxyl radicals by the ra-
diolysis of water yields cleavage products
that are comparable with Fe(II)-EDTA–de-
pendent reactions (7, 12). The high flux
provided by white-light x-ray beams at
the National Synchrotron Light Source
(NSLS) permits footprinting of the ri-
bozyme to be accomplished with millisec-
ond time resolution (7).
The ribozyme derived from the Tetrahy-
mena group I intron (Fig. 1A) folds into a
well-defined tertiary structure in the pres-
ence of Mg21, and Mg21 is required for
catalytic activity (1). The ribozyme con-
tains at least three domains of tertiary struc-
ture (13) that, when separated, can reasso-
ciate to form the active ribozyme (14). The
domain containing paired regions P4-P6
(Fig. 1A) folds independently (10, 15), and
formation of P4-P6 has been proposed to be
the first step in the folding pathway of the
ribozyme (3, 16). In earlier experiments in
which RNA was manually mixed with
Mg21 before exposure to the x-ray beam, we
showed that the tertiary structure of the
P4-P6 domain is formed within 30 s, the
initial time of the assay (7).
To resolve early steps in the ribozyme
folding pathway, we installed a stopped-
flow apparatus with an x-ray exposure
chamber on NSLS beamline X-9A (17).
The flux of X-9A absorbed by the sample
was sufficient to cleave 20% of the RNA
molecules with exposures as short as 10 ms
(18). Folding reactions were begun by mix-
ing RNA with buffer containing Mg21,t oa
final concentration of 10 mM (19). Sam-
ples were irradiated at a series of times after
mixing, and the hydroxyl radical cleavage
products were separated by gel electro-
phoresis (19). The ribozyme was fully active
after passage through the stopped-flow ap-
paratus (20), verifying that the RNA had
folded correctly under these experimental
conditions.
We determined the folding kinetics of
the ribozyme by quantitating the changes
in solvent accessibility of individual sites
as a function of time (Fig. 2) (7, 21). After
the addition of Mg21, specific nucleotides
within the P4-P6 domain became protect-
ed from cleavage within 100 ms (22), and
the extent of protection reached a plateau
within several seconds (Fig. 2). Compari-
son of this plateau with control reactions,
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